Nyon

NYON, Switzerland and PHILADELPHIA, November 18, 2011 - Shionogi and Shire to jointly develop and commercialize ADHD medicines in Japan Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has entered into an agreement with Shionogi & Co.

NYON, Switzerland, October 20, 2011 - This World Osteoporosis Day (October 20) the International Osteoporosis Foundation (IOF) and its 200 member patient and medical societies are calling on the public and health professionals around the world to take action for bone health and osteoporosis prevention.

NYON, Switzerland, October 13, 2011 - For this year's World Osteoporosis Day (October 20), the International Osteoporosis Foundation (IOF) is releasing a 24-page report promoting a three-step strategy for healthy bones and strong muscles.

NYON, Switzerland, August 31, 2011 - - Data Presented at the 2011 Annual Symposium of the Society for the Study of Inborn Errors of Metabolism (SSIEM) Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced positive data from several studies designed to evaluate the safety of switching to REPLAGAL (agalsidase alfa) from Fabrazyme (agalsidase beta) and the long-term safety and benefits of switching to VPRIV (velaglucerase alfa) from Cerezyme (imiglucerase).

NYON, Switzerland, August 30, 2011 - Inmarsat's Next Generation Satellites Will Support the Growing Demand for Data Connectivity on Aircraft Inmarsat (LSE:ISAT), the leading provider of global mobile satellite communications services, is pleased to announce it has reached agreement in principle with Rockwell Collins (NYSE: COL) by which Rockwell Collins will take the leading role in development, production and distribution of User Terminals (UTs) for future Inmarsat's Global Xpress™ (GX) aeronautical services to the aviation industry.